Keyphrases
Acute Myeloid Leukemia
99%
Leukemia
23%
Acute Lymphoblastic Leukemia
20%
Newly Diagnosed
19%
Chronic Myeloid Leukemia
18%
Leukemia Patients
16%
Complete Remission
15%
Venetoclax
12%
Protein Expression
12%
Relapsed or Refractory Acute Myeloid Leukemia
11%
Overall Survival
10%
Myelodysplastic Syndrome
10%
Cytarabine
10%
Philadelphia Chromosome
9%
Reverse Phase Protein Array
9%
Hematological Malignancies
8%
Phase II Study
8%
Acute Myeloid Leukemia Cells
8%
Leukemic Cells
8%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
7%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
7%
Chemotherapy
7%
B-cell Lymphoma 2 (Bcl-2)
7%
Relapsed or Refractory
7%
Interferon-α (IFN-α)
6%
Apoptosis
6%
Cytogenetic Response
6%
Older Patients
6%
Decitabine
6%
Proteomics
6%
Gemtuzumab Ozogamicin
6%
Therapeutic Target
5%
Intensive Chemotherapy
5%
Phosphorylation
5%
Pediatric Leukemia
5%
Idarubicin
5%
Proteomic Profiling
5%
Acute Promyelocytic Leukemia
5%
Chronic Phase
5%
Hypomethylating Agents
5%
Minimal Residual Disease
5%
Bone Marrow
5%
Imatinib Mesylate
5%
Chronic Lymphocytic Leukemia
5%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Cytogenetics
21%
Proteomics
21%
Protein Expression
20%
Protein Microarray
18%
B Cell
15%
Programmed Cell Death
14%
Drug Resistance
14%
Overall Survival
13%
Genetics
9%
CD34
9%
Genomics
8%
T Cell
8%
Philadelphia Chromosome
8%
Hematopoietic Cell
6%
Cytarabine
6%
P53
6%
Receptor Tyrosine Kinase
6%
Tyrosine Kinase
6%
DNA Damage Response
6%
Methylation
6%
Stem Cell
6%
Progenitor Cell
5%
Promoter Region
5%
Transcription Factor
5%
Signal Transduction
5%
RUNX1
5%
Enzyme
5%
Karyotype
5%
Enhancer Region
5%
Medicine and Dentistry
Acute Myeloid Leukemia
75%
Acute Lymphoblastic Leukemia
23%
Leukemia
20%
Protein Expression
16%
Myelodysplastic Syndrome
14%
Overall Survival
11%
Proteomics
11%
Cytarabine
11%
Venetoclax
10%
Chronic Myelogenous Leukemia
9%
Leukemia Cell
9%
Hematologic Malignancy
8%
Programmed Cell Death
8%
Pediatrics
8%
Diseases
7%
Hematopoietic Cell
7%
Oncology
6%
Protein Microarray
6%
Acute Myelogenous Leukemia
6%
Decitabine
5%
Philadelphia 1 Chromosome
5%
Acute Leukemia
5%
B-Cell Chronic Lymphocytic Leukemia
5%
Cancer
5%
